Lipid-Laden Macrophages in Pulmonary Diseases

29Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary surfactants play a crucial role in managing lung lipid metabolism, and dysregulation of this process is evident in various lung diseases. Alternations in lipid metabolism lead to pulmonary surfactant damage, resulting in hyperlipidemia in response to lung injury. Lung macrophages are responsible for recycling damaged lipid droplets to maintain lipid homeostasis. The inflammatory response triggered by external stimuli such as cigarette smoke, bleomycin, and bacteria can interfere with this process, resulting in the formation of lipid-laden macrophages (LLMs), also known as foamy macrophages. Recent studies have highlighted the potential significance of LLM formation in a range of pulmonary diseases. Furthermore, growing evidence suggests that LLMs are present in patients suffering from various pulmonary conditions. In this review, we summarize the essential metabolic and signaling pathways driving the LLM formation in chronic obstructive pulmonary disease, pulmonary fibrosis, tuberculosis, and acute lung injury.

Cite

CITATION STYLE

APA

Zhu, Y., Choi, D., Somanath, P. R., & Zhang, D. (2024, June 1). Lipid-Laden Macrophages in Pulmonary Diseases. Cells. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/cells13110889

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free